|Day's Range||48.64 - 48.90|
|52 Week Range||31.47 - 49.53|
|PE Ratio (TTM)||-69.64|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
On April 14, 2017, Abbott Laboratories (ABT) agreed to acquire point-of-care diagnostics player Alere (ALR) for an equity value of ~$5.3 billion.
Surging implied volatility makes Alere (ALR) Stock lucrative to the option traders.
David Einhorn is going all-in on General Motors.